Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

New decision-making methods to improve access to orphan drugs

    • 10 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    New decision-making methods to improve access to orphan drugs. Pharmacoecon. Outcomes News 436, 2 (2003). https://doi.org/10.1007/BF03276950

    Download citation

    Keywords

    • Rare Disease
    • Orphan Drug
    • Health Spending
    • Marketing Authorisation
    • Innovative Therapy